HEPA

Hepion Pharmaceuticals

Delisted

HEPA was delisted on the 12th of May, 2025.

16 hedge funds and large institutions have $5.43M invested in Hepion Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
-10
Holders Change %
-38.46%
% of All Funds
0.25%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
5
Reduced
4
Closed
12
Calls
$46K
Puts
Net Calls
+$46K
Net Calls Change
-$98K
Name Holding Trade Value Shares
Change
Shares
Change %
PAM
26
PVG Asset Management
Colorado
-$47.5K -61 Closed
VF
27
Virtu Financial
New York
-$42K -54 Closed
Charles Schwab
28
Charles Schwab
California
-$24.5K -32 Closed
Two Sigma Advisers
29
Two Sigma Advisers
New York
-$20.1K -26 Closed
Cetera Investment Advisers
30
Cetera Investment Advisers
Illinois
-$15.3K -20 Closed
IGGA
31
Iron Gate Global Advisors
Utah
-$10.3K -13 Closed
AWA
32
Amplius Wealth Advisors
Pennsylvania
-$7.77K -10 Closed
Citadel Advisors
33
Citadel Advisors
Florida
-$1.28K -2 Closed